Julie L. Gerberding

CIK 1628884 · EVP, Chief Patient Officer · last filed 2025-09-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.80M

Companies

4

Total Filings

39

Lifetime Open-Market Net

-$31.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HilleVax, Inc. (HLVX) Delisted Director 0 $2.09 $0 $0 5 2025-09-17
MCK Director $784.05 $0 2 2025-07-31
CERNER Corp (CERN) Delisted Director 0 $94.92 $0 -$569.4K 8 2022-06-09
MRK EVP, Chief Patient Officer 48,712 $119.05 $5.80M -$31.27M 24 2022-02-28

Recent Filings · Page 4 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-06 CERNER Corp (CERN) Delisted Grant (A) +4,500 $0 EDGAR
2017-03-01 MRK Grant (A) +3,707 $244.1K EDGAR
2016-11-08 MRK Mixed -$1.58M EDGAR
2016-05-12 MRK Grant (A) $0 EDGAR
2016-05-09 MRK Mixed +2,436 -$84.7K EDGAR
2016-02-24 MRK Grant (A) +3,377 $171.5K EDGAR
2015-05-11 MRK Mixed +7,840 -$709.6K EDGAR
2015-05-05 MRK Mixed +2,604 -$72.7K EDGAR
2015-02-25 MRK Grant (A) +2,736 $159.5K EDGAR
Showing 3139 of 39
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.